Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Oct/15/2022 15 20
Tenofovir Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021 4 3
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021 25 9
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021 26 15
Baicalin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 5 0
Teniposide Potential treatment - theoretical effect Experimental Antiviral Apr/12/2021 3 0
Glycyrrhizic acid Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 5 0
Cyclosporine Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/23/2021 7 0
Excel (.xslx) CSV (.csv)